On the way from invention to innovation: the role of applicant and inventor team characteristics / Mariia Shkolnykova
This paper investigates the impact of applicant and inventor team composition on patent commercialization in form of product creation. It outlines the importance of applicant and inventor team characteristics, i.e. specifically, size and internationality, on the speed of market authorization of a patent-related product and on the product quality. The analysis is performed for the European pharmaceutical industry. The product data is taken from the European Medicines Agency website for the period 2010-2019. Manual patent-product concordance is established with the help of the Pat-INFORMED database from the World Intellectual Property Organization and the Health Canada database. The created dataset presents combined data on patent and product characteristics. Results from an accelerated failure time model show that larger applicant teams as well as the presence of international applicants and inventors decelerate the market authorization of patent-related products. Results of the probit analysis show that larger inventor teams lead to patents of higher quality..
| Medienart: |
E-Book |
|---|
| Erscheinungsjahr: |
December 2021 |
|---|---|
| Erschienen: |
Bremen: University of Bremen, Faculty of Business Studies & Economics, Institute for Economic Research and Policy (ierp) ; December 2021 |
| Reihe: |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Shkolnykova, Mariia [VerfasserIn] |
|---|
| Links: |
dx.doi.org [kostenfrei] |
|---|
| Themen: |
Commercialization |
|---|
| Umfang: |
1 Online-Ressource (27 Seiten) |
|---|
| doi: |
10.26092/elib/1284 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
1782095497 |
|---|
| LEADER | 01000cam a2200265 4500 | ||
|---|---|---|---|
| 001 | 1782095497 | ||
| 003 | DE-627 | ||
| 005 | 20230426163136.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 211214s2021 gw |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.26092/elib/1284 |2 doi | |
| 035 | |a (DE-627)1782095497 | ||
| 035 | |a (DE-599)KXP1782095497 | ||
| 035 | |a (OCoLC)1288422189 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 044 | |c XA-DE-HB | ||
| 100 | 1 | |a Shkolnykova, Mariia |e verfasserin |0 (orcid)0000-0002-7186-619X |4 aut | |
| 245 | 1 | 0 | |a On the way from invention to innovation: the role of applicant and inventor team characteristics |c Mariia Shkolnykova |
| 264 | 1 | |a Bremen |b University of Bremen, Faculty of Business Studies & Economics, Institute for Economic Research and Policy (ierp) |c December 2021 | |
| 300 | |a 1 Online-Ressource (27 Seiten) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Bremen papers on economics & innovation |v 2110 | |
| 520 | |a This paper investigates the impact of applicant and inventor team composition on patent commercialization in form of product creation. It outlines the importance of applicant and inventor team characteristics, i.e. specifically, size and internationality, on the speed of market authorization of a patent-related product and on the product quality. The analysis is performed for the European pharmaceutical industry. The product data is taken from the European Medicines Agency website for the period 2010-2019. Manual patent-product concordance is established with the help of the Pat-INFORMED database from the World Intellectual Property Organization and the Health Canada database. The created dataset presents combined data on patent and product characteristics. Results from an accelerated failure time model show that larger applicant teams as well as the presence of international applicants and inventors decelerate the market authorization of patent-related products. Results of the probit analysis show that larger inventor teams lead to patents of higher quality. | ||
| 540 | |q DE-46 |a Namensnennung 3.0 Deutschland |f CC BY 3.0 DE |2 cc |u http://creativecommons.org/licenses/by-nc-nd/3.0/de/ | ||
| 583 | 1 | |a Archivierung/Langzeitarchivierung gewährleistet |f PEHB |2 pdager |5 DE-46 | |
| 650 | 4 | |a patent | |
| 650 | 4 | |a commercialization | |
| 650 | 4 | |a pharmaceutical industry | |
| 650 | 4 | |a survival analysis | |
| 650 | 4 | |a probit regression | |
| 830 | 0 | |a Bremen papers on economics & innovation |v 2110 |9 2110 |w (DE-627)1668340291 |w (DE-600)2976634-5 |x 2629-3994 |7 ns | |
| 856 | 4 | 0 | |u http://dx.doi.org/10.26092/elib/1284 |x Resolving-System |z kostenfrei |
| 912 | |a GBV_ILN_21 | ||
| 912 | |a ISIL_DE-46 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_2403 | ||
| 912 | |a ISIL_DE-LFER | ||
| 935 | |i DSpace | ||
| 951 | |a BO | ||
| 980 | |2 21 |1 01 |x 0046 |b 402005665X |h epflicht_2021 |k Kostenloser Zugriff |y zza |z 14-12-21 | ||
| 980 | |2 2403 |1 01 |x DE-LFER |b 4044822042 |c 00 |f --%%-- |d --%%-- |e n |j --%%-- |y l01 |z 26-01-22 | ||
| 981 | |2 21 |1 01 |x 0046 |r http://dx.doi.org/10.26092/elib/1284 |z LF | ||
| 981 | |2 2403 |1 01 |x DE-LFER |r http://dx.doi.org/10.26092/elib/1284 | ||
| 982 | |2 21 |1 00 |x DE-46 |8 00 |a Universität Bremen | ||
| 982 | |2 21 |1 00 |x DE-46 |8 00 |a Fachbereich 07: Wirtschaftswissenschaft (FB 07) | ||
| 982 | |2 21 |1 00 |x DE-46 |8 00 |a Institute for Economic Research and Policy (IERP) | ||
| 995 | |2 21 |1 01 |x 0046 |a epflicht_2021 | ||